{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:15:08Z","timestamp":1785233708353,"version":"3.55.0"},"reference-count":201,"publisher":"National Institute for Health and Care Research","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["NIHR129713"],"award-info":[{"award-number":["NIHR129713"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"<jats:sec id=\"abs1-1\"><jats:title>Background<\/jats:title>\n<jats:p>Lynch syndrome is an inherited condition which leads to an increased risk of colorectal, endometrial and ovarian cancer. Risk-reducing surgery is generally recommended to manage the risk of gynaecological cancer once childbearing is completed. The value of gynaecological colonoscopic surveillance as an interim measure or instead of risk-reducing surgery is uncertain. We aimed to determine whether gynaecological surveillance was effective and cost-effective in Lynch syndrome.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-2\"><jats:title>Methods<\/jats:title>\n<jats:p>We conducted systematic reviews of the effectiveness and cost-effectiveness of gynaecological cancer surveillance in Lynch syndrome, as well as a systematic review of health utility values relating to cancer and gynaecological risk reduction. Study identification included bibliographic database searching and citation chasing (searches updated 3 August 2021). Screening and assessment of eligibility for inclusion were conducted by independent researchers. Outcomes were prespecified and were informed by clinical experts and patient involvement. Data extraction and quality appraisal were conducted and results were synthesised narratively.<\/jats:p>\n<jats:p>We also developed a whole-disease economic model for Lynch syndrome using discrete event simulation methodology, including natural history components for colorectal, endometrial and ovarian cancer, and we used this model to conduct a cost\u2013utility analysis of gynaecological risk management strategies, including surveillance, risk-reducing surgery and doing nothing.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-3\"><jats:title>Results<\/jats:title>\n<jats:p>We found 30 studies in the review of clinical effectiveness, of which 20 were non-comparative (single-arm) studies. There were no high-quality studies providing precise outcome estimates at low risk of bias. There is some evidence that mortality rate is higher for surveillance than for risk-reducing surgery but mortality is also higher for no surveillance than for surveillance. Some asymptomatic cancers were detected through surveillance but some cancers were also missed. There was a wide range of pain experiences, including some individuals feeling no pain and some feeling severe pain. The use of pain relief (e.g. ibuprofen) was common, and some women underwent general anaesthetic for surveillance.<\/jats:p>\n<jats:p>Existing economic evaluations clearly found that risk-reducing surgery leads to the best lifetime health (measured using quality-adjusted life-years) and is cost-effective, while surveillance is not cost-effective in comparison. Our economic evaluation found that a strategy of surveillance alone or offering surveillance and risk-reducing surgery was cost-effective, except for <jats:italic>path_PMS2<\/jats:italic> Lynch syndrome. Offering only risk-reducing surgery was less effective than offering surveillance with or without surgery.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-4\"><jats:title>Limitations<\/jats:title>\n<jats:p>Firm conclusions about clinical effectiveness could not be reached because of the lack of high-quality research. We did not assume that women would immediately take up risk-reducing surgery if offered, and it is possible that risk-reducing surgery would be more effective and cost-effective if it was taken up when offered.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-5\"><jats:title>Conclusions<\/jats:title>\n<jats:p>There is insufficient evidence to recommend for or against gynaecological cancer surveillance in Lynch syndrome on clinical grounds, but modelling suggests that surveillance could be cost-effective. Further research is needed but it must be rigorously designed and well reported to be of benefit.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-6\"><jats:title>Study registration<\/jats:title>\n<jats:p>This study is registered as PROSPERO CRD42020171098.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-7\"><jats:title>Funding<\/jats:title>\n<jats:p>This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: NIHR129713) and is published in full in <jats:italic>Health Technology Assessment<\/jats:italic>; Vol. 28, No. 41. See the NIHR Funding and Awards website for further award information.<\/jats:p>\n<\/jats:sec>","DOI":"10.3310\/vbxx6307","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T06:32:35Z","timestamp":1725863555000},"page":"1-228","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Gynaecological cancer surveillance for women with Lynch syndrome: systematic review and cost-effectiveness evaluation"],"prefix":"10.3310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-2819","authenticated-orcid":true,"given":"Tristan M","family":"Snowsill","sequence":"first","affiliation":[{"name":"Health Economics Group, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4799-4300","authenticated-orcid":true,"given":"Helen","family":"Coelho","sequence":"additional","affiliation":[{"name":"Peninsula Technology Assessment Group, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7206-4957","authenticated-orcid":true,"given":"Nia G","family":"Morrish","sequence":"additional","affiliation":[{"name":"Health Economics Group, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6982-4521","authenticated-orcid":true,"given":"Simon","family":"Briscoe","sequence":"additional","affiliation":[{"name":"Exeter Policy Research Programme Evidence Review Facility, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9135-5488","authenticated-orcid":true,"given":"Kate","family":"Boddy","sequence":"additional","affiliation":[{"name":"NIHR Collaborations for Leadership in Applied Health Research and Care South West Peninsula, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Smith","sequence":"additional","affiliation":[{"name":"Lynch Syndrome, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0284-8630","authenticated-orcid":true,"given":"Emma J","family":"Crosbie","sequence":"additional","affiliation":[{"name":"Division of Cancer Sciences, School of Medical Sciences, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3117-3257","authenticated-orcid":true,"given":"Neil AJ","family":"Ryan","sequence":"additional","affiliation":[{"name":"The Academic Women\u2019s Health Unit, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0612-8377","authenticated-orcid":true,"given":"Fiona","family":"Lalloo","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Manchester University Hospitals Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2077-0419","authenticated-orcid":true,"given":"Claire T","family":"Hulme","sequence":"additional","affiliation":[{"name":"Health Economics Group, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2024,8]]},"reference":[{"key":"key2024090911500500_ref1-bib1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1158\/1055-9965.EPI-16-0693","article-title":"Prevalence and penetrance of major genes and polygenes for colorectal cancer","volume":"26","author":"Win","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key2024090911500500_ref2-bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","article-title":"Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database","volume":"22","author":"Dominguez-Valentin","year":"2020","journal-title":"Genet Med"},{"key":"key2024090911500500_ref3-bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/gyno.2001.6279","article-title":"The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer","volume":"82","author":"Watson","year":"2001","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref4-bib4","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","article-title":"Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial","volume":"378","author":"Burn","year":"2011","journal-title":"Lancet"},{"key":"key2024090911500500_ref5-bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0016-5085(00)70168-5","article-title":"Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer","volume":"118","author":"J\u00e4rvinen","year":"2000","journal-title":"Gastroenterology"},{"key":"key2024090911500500_ref6-bib6","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/s41436-019-0489-y","article-title":"The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome","volume":"21","author":"Crosbie","year":"2019","journal-title":"Genet Med"},{"key":"key2024090911500500_ref7-bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome","volume":"354","author":"Schmeler","year":"2006","journal-title":"N Engl J Med"},{"key":"key2024090911500500_ref8-bib8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gutjnl-2015-309675","article-title":"Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database","volume":"66","author":"M\u00f8ller","year":"2017","journal-title":"Gut"},{"key":"key2024090911500500_ref9-bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21510","article-title":"Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation","volume":"21","author":"Snowsill","year":"2017","journal-title":"Health Technol Assess"},{"key":"key2024090911500500_ref10-bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18580","article-title":"A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome","volume":"18","author":"Snowsill","year":"2014","journal-title":"Health Technol Assess"},{"key":"key2024090911500500_ref11-bib11","first-page":"180","article-title":"Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications","volume":"1","author":"Bonis","year":"2007","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"key":"key2024090911500500_ref12-bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.pas.0000146009.85309.3b","article-title":"Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms","volume":"29","author":"Shia","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"key2024090911500500_ref13-bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"key2024090911500500_ref14-bib14","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"key":"key2024090911500500_ref16-bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmg.2007.048991","article-title":"Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)","volume":"44","author":"Vasen","year":"2007","journal-title":"J Med Genet"},{"key":"key2024090911500500_ref17-bib17","volume-title":"Molecular Testing Strategies for Lynch Syndrome in People with Colorectal Cancer (DG27)","author":"National Institute for Health and Care Excellence (NICE)","year":"2017"},{"key":"key2024090911500500_ref18-bib18","volume-title":"Testing Strategies for Lynch Syndrome in People with Endometrial Cancer (DG42)","author":"National Institute for Health and Care Excellence (NICE)","year":"2020"},{"key":"key2024090911500500_ref19-bib19","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0016-5085(99)70510-X","article-title":"New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC","volume":"116","author":"Vasen","year":"1999","journal-title":"Gastroenterology"},{"key":"key2024090911500500_ref20-bib20","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","article-title":"Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts","volume":"62","author":"Vasen","year":"2013","journal-title":"Gut"},{"key":"key2024090911500500_ref21-bib21","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1200\/JCO.2008.17.5950","article-title":"Feasibility of screening for Lynch syndrome among patients with colorectal cancer","volume":"26","author":"Hampel","year":"2008","journal-title":"J Clin Oncol"},{"key":"key2024090911500500_ref22-bib22","doi-asserted-by":"crossref","first-page":"e1003263","DOI":"10.1371\/journal.pmed.1003263","article-title":"The proportion of endometrial tumours associated with Lynch syndrome (PETALS): a prospective cross-sectional study","volume":"17","author":"Ryan","year":"2020","journal-title":"PLOS Med"},{"key":"key2024090911500500_ref23-bib23","volume-title":"Cancer Registration Statistics, England, 2017","author":"Office for National Statistics","year":"2019"},{"key":"key2024090911500500_ref25-bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.2015.6789","article-title":"Female hormonal factors and the risk of endometrial cancer in Lynch syndrome","volume":"314","author":"Dashti","year":"2015","journal-title":"JAMA"},{"key":"key2024090911500500_ref28-bib28","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ygyno.2018.11.027","article-title":"Women\u2019s preferences for cancer risk management strategies in Lynch syndrome","volume":"152","author":"Sun","year":"2019","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref29-bib29","volume-title":"Ovarian Cancer: The Recognition and Initial Management of Ovarian Cancer (CG122)","author":"National Institute for Health and Care Excellence (NICE)","year":"2011"},{"key":"key2024090911500500_ref30-bib30","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"key2024090911500500_ref31-bib31","volume-title":"CASP Cohort Study Checklist [Online]","author":"Critical Appraisal Skills Programme (CASP)","year":"2018"},{"key":"key2024090911500500_ref32-bib32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"key2024090911500500_ref33-bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-0004.2008.01125.x","article-title":"Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations","volume":"75","author":"Barrow","year":"2009","journal-title":"Clin Genet"},{"key":"key2024090911500500_ref34-bib34","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.ygyno.2013.04.297","article-title":"Diagnostic value of microsatellite instability analysis in uterine cavity washings to detect endometrial cancer in Lynch syndrome","volume":"130","author":"Bats","year":"2013","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref35-bib35","first-page":"3211","article-title":"Microsatellite instability analysis in uterine cavity washings to detect endometrial cancer in Lynch syndrome","volume":"34","author":"Bats","year":"2014","journal-title":"Anticancer Res"},{"key":"key2024090911500500_ref36-bib36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s12885-020-06926-x","article-title":"Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study","volume":"20","author":"Bucksch","year":"2020","journal-title":"BMC Cancer"},{"key":"key2024090911500500_ref37-bib37","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/cncr.10380","article-title":"The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma","volume":"94","author":"Dove-Edwin","year":"2002","journal-title":"Cancer"},{"key":"key2024090911500500_ref38-bib38","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.3390\/cancers12113419","article-title":"Correction: Due\u00f1as et al. Assessing effectiveness of colonic and gynecological risk reducing surgery in Lynch syndrome individuals","volume":"12","author":"Due\u00f1as","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key2024090911500500_ref39-bib39","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.3390\/cancers12113419","article-title":"Assessing effectiveness of colonic and gynecological risk reducing surgery in Lynch syndrome individuals","volume":"12","author":"Due\u00f1as","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key2024090911500500_ref40-bib40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3390\/cancers13030459","article-title":"Gynecological surveillance and surgery outcomes in Dutch Lynch syndrome carriers","volume":"13","author":"Eikenboom","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key2024090911500500_ref41-bib41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10689-009-9259-3","article-title":"Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study","volume":"8","author":"Elmasry","year":"2009","journal-title":"Fam Cancer"},{"key":"key2024090911500500_ref42-bib42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10689-009-9252-x","article-title":"Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome","volume":"8","author":"Gerritzen","year":"2009","journal-title":"Fam Cancer"},{"key":"key2024090911500500_ref43-bib43","first-page":"S1067","article-title":"Annual gynaecological surveillance in women with Lynch syndrome: what\u2019s the additional value of microcurettage?","volume":"21","author":"Helder-Woolderink","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"key2024090911500500_ref44-bib44","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2013.05.032","article-title":"The additional value of endometrial sampling in the early detection of endometrial cancer in women with Lynch syndrome","volume":"131","author":"Helder-Woolderink","year":"2013","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref45-bib45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10689-016-9937-x","article-title":"Pain evaluation during gynaecological surveillance in women with Lynch syndrome","volume":"16","author":"Helder-Woolderink","year":"2017","journal-title":"Fam Cancer"},{"key":"key2024090911500500_ref46-bib46","first-page":"1557","article-title":"Perception of pain at gynaecological surveillance in women with Lynch syndrome","volume":"25","author":"Helder-Woolderink","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"key2024090911500500_ref47-bib47","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ygyno.2014.03.012","article-title":"The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer","volume":"133","author":"Ketabi","year":"2014","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref48-bib48","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/00016340802443806","article-title":"Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families","volume":"87","author":"Boilesen","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key2024090911500500_ref49-bib49","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10689-007-9123-2","article-title":"Hysteroscopic findings in women at risk of HNPCC. Results of a prospective observational study","volume":"6","author":"L\u00e9curu","year":"2007","journal-title":"Fam Cancer"},{"key":"key2024090911500500_ref50-bib50","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1525-1438.2007.01183.x","article-title":"Performance of office hysteroscopy and endometrial biopsy for detecting endometrial disease in women at risk of human non-polyposis colon cancer: a prospective study","volume":"18","author":"L\u00e9curu","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"key2024090911500500_ref51-bib51","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/IGC.0b013e3181d7283a","article-title":"Contribution of ultrasonography to endometrial cancer screening in patients with hereditary nonpolyposis colorectal cancer\/Lynch syndrome","volume":"20","author":"L\u00e9curu","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"key2024090911500500_ref52-bib52","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00404-012-2492-2","article-title":"Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC\/Lynch syndrome (LS)","volume":"286","author":"Manchanda","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"key2024090911500500_ref53-bib53","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/gutjnl-2016-311403","article-title":"Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database","volume":"66","author":"M\u00f8ller","year":"2017","journal-title":"Gut"},{"key":"key2024090911500500_ref54-bib54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JOP.2010.000038","article-title":"Prospective study of combined colon and endometrial cancer screening in women with Lynch syndrome: a patient-centered approach","volume":"7","author":"Huang","year":"2011","journal-title":"J Oncol Pract"},{"key":"key2024090911500500_ref55-bib55","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1200\/jco.2010.28.15_suppl.1563","article-title":"A prospective study of combined colon and endometrial cancer screening in women with Lynch syndrome: a novel, patient-centered approach","volume":"28","author":"Huang","year":"2010","journal-title":"J Clin Oncol"},{"key":"key2024090911500500_ref56-bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10689-019-00124-w","article-title":"International society for gastrointestinal hereditary tumours-InSiGHT","volume":"18","author":"Nebgen","year":"2019","journal-title":"Fam Cancer"},{"key":"key2024090911500500_ref57-bib57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ygyno.2014.08.017","article-title":"Combined colonoscopy and endometrial biopsy cancer screening results in women with Lynch syndrome","volume":"135","author":"Nebgen","year":"2014","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref58-bib58","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/j.ygyno.2013.04.296","article-title":"Endometrial cancer screening in Lynch syndrome: do patients report symptoms prior to diagnosis?","volume":"130","author":"Ring","year":"2013","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref59-bib59","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10689-012-9537-3","article-title":"Causes of death of mutation carriers in Finnish Lynch syndrome families","volume":"11","author":"Pylv\u00e4n\u00e4inen","year":"2012","journal-title":"Fam Cancer"},{"key":"key2024090911500500_ref60-bib60","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1200\/JCO.2009.23.7784","article-title":"Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members","volume":"27","author":"J\u00e4rvinen","year":"2009","journal-title":"J Clin Oncol"},{"key":"key2024090911500500_ref61-bib61","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ijc.22446","article-title":"Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome","volume":"120","author":"Renkonen-Sinisalo","year":"2007","journal-title":"Int J Cancer"},{"key":"key2024090911500500_ref62-bib62","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0090-8258(03)00371-8","article-title":"Gynecologic screening in hereditary nonpolyposis colorectal cancer","volume":"91","author":"Rijcken","year":"2003","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref63-bib63","doi-asserted-by":"crossref","first-page":"E1196","DOI":"10.1097\/IGC.0b013e318251cc3f","article-title":"Incidental diagnosis of endometrial cancer during the UK familial ovarian cancer screening study (UKFOCSS)","volume":"22","author":"Rosenthal","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"key2024090911500500_ref64-bib64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1200\/JCO.2011.39.7638","article-title":"Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule","volume":"31","author":"Rosenthal","year":"2013","journal-title":"J Clin Oncol"},{"key":"key2024090911500500_ref65-bib65","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ygyno.2017.01.005","article-title":"Pathological features and clinical behavior of Lynch syndrome-associated ovarian cancer","volume":"144","author":"Ryan","year":"2017","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref66-bib66","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1399-0004.2012.01929.x","article-title":"Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation","volume":"83","author":"Stuckless","year":"2013","journal-title":"Clin Genet"},{"key":"key2024090911500500_ref67-bib67","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ygyno.2015.07.016","article-title":"The gynecological surveillance of women with Lynch syndrome in Sweden","volume":"138","author":"Tzortzatos","year":"2015","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref68-bib68","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1525-1438.2007.01009.x","article-title":"Does a \u2018one-stop\u2019 gynecology screening clinic for women in hereditary nonpolyposis colorectal cancer families have an impact on their psychological morbidity and perception of health?","volume":"18","author":"Wood","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"key2024090911500500_ref69-bib69","first-page":"90","article-title":"Characteristics of ovarian cancer in women with Lynch syndrome","volume":"27","author":"Helder-Woolderink","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"key2024090911500500_ref70-bib70","first-page":"713","article-title":"Characteristics of ovarian cancer in women with Lynch syndrome","volume":"26","author":"Helder-Woolderink","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"key2024090911500500_ref71-bib71","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ygyno.2018.03.060","article-title":"Characteristics of Lynch syndrome associated ovarian cancer","volume":"150","author":"Woolderink","year":"2018","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref72-bib72","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12905-020-00920-y","article-title":"Feasibility of endometrial sampling by vaginal tampons in women with Lynch syndrome","volume":"20","author":"Woolderink","year":"2020","journal-title":"BMC Womens Health"},{"key":"key2024090911500500_ref73-bib73","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/j.gastro.2005.11.032","article-title":"Decrease in mortality in Lynch syndrome families because of surveillance","volume":"130","author":"de Jong","year":"2006","journal-title":"Gastroenterology"},{"key":"key2024090911500500_ref74-bib74","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10689-020-00158-5","article-title":"Factors associated with decision-making on prophylactic hysterectomy and attitudes towards gynecological surveillance among women with Lynch syndrome (LS): a descriptive study","volume":"19","author":"Kalamo","year":"2020","journal-title":"Fam Cancer"},{"key":"key2024090911500500_ref75-bib75","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/1471-0528.16432","article-title":"A mismatch in care: results of a United Kingdom-wide patient and clinician survey of gynaecological services for women with Lynch syndrome","volume":"128","author":"Ryan","year":"2021","journal-title":"BJOG"},{"key":"key2024090911500500_ref76-bib76","volume-title":"United Kingdom Familial Ovarian Cancer Screening Study","author":"ISRCTN Registry","year":"2010"},{"key":"key2024090911500500_ref77-bib77","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.7326\/M21-2234","article-title":"QUADAS-C: a tool for assessing risk of bias in comparative diagnostic accuracy studies","volume":"174","author":"Yang","year":"2021","journal-title":"Ann Intern Med"},{"key":"key2024090911500500_ref78-bib78","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00019053-200624040-00006","article-title":"Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment","volume":"24","author":"Philips","year":"2006","journal-title":"PharmacoEcon"},{"key":"key2024090911500500_ref79-bib79","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/cncr.23554","article-title":"Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome","volume":"113","author":"Kwon","year":"2008","journal-title":"Cancer"},{"key":"key2024090911500500_ref80-bib80","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10689-011-9444-z","article-title":"A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) families","volume":"10","author":"Yang","year":"2011","journal-title":"Fam Cancer"},{"key":"key2024090911500500_ref81-bib81","doi-asserted-by":"crossref","first-page":"e2123616","DOI":"10.1001\/jamanetworkopen.2021.23616","article-title":"Cost-effectiveness analysis of genotype-specific surveillance and preventive strategies for gynecologic cancers among women with Lynch syndrome","volume":"4","author":"Wright","year":"2021","journal-title":"JAMA Netw Open"},{"key":"key2024090911500500_ref82-bib82","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLOS Med"},{"key":"key2024090911500500_ref83-bib83","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/(SICI)1099-1050(199709)6:5<491::AID-HEC293>3.0.CO;2-R","article-title":"Trying to do better than average: a commentary on \u2018statistical inference for cost-effectiveness ratios\u2019","volume":"6","author":"Briggs","year":"1997","journal-title":"Health Econ"},{"key":"key2024090911500500_ref84-bib84","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000267500.27329.85","article-title":"Gynecologic cancer prevention in Lynch syndrome\/hereditary nonpolyposis colorectal cancer families","volume":"110","author":"Chen","year":"2007","journal-title":"Obstet Gynecol"},{"key":"key2024090911500500_ref85-bib85","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jval.2013.02.017","article-title":"Systematic searching and selection of health state utility values from the literature","volume":"16","author":"Papaioannou","year":"2013","journal-title":"Value Health"},{"key":"key2024090911500500_ref86-bib86","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(00)03615-1","article-title":"Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial","volume":"357","author":"Hurskainen","year":"2001","journal-title":"Lancet"},{"key":"key2024090911500500_ref87-bib87","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.291.12.1456","article-title":"Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up","volume":"291","author":"Hurskainen","year":"2004","journal-title":"JAMA"},{"key":"key2024090911500500_ref88-bib88","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/cncr.27634","article-title":"Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome","volume":"119","author":"Kuppermann","year":"2013","journal-title":"Cancer"},{"key":"key2024090911500500_ref89-bib89","first-page":"283","article-title":"The quality of life associated with prophylactic treatments for women with BRCA1\/2 mutations","volume":"5","author":"Grann","year":"1999","journal-title":"Cancer J Sci Am"},{"key":"key2024090911500500_ref90-bib90","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1200\/JCO.1998.16.3.979","article-title":"Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients","volume":"16","author":"Grann","year":"1998","journal-title":"J Clin Oncol"},{"key":"key2024090911500500_ref91-bib91","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2147\/CEOR.S92078","article-title":"Estimating health-state utility values for patients with recurrent ovarian cancer using functional assessment of cancer therapy \u2013 general mapping algorithms","volume":"7","author":"Hettle","year":"2015","journal-title":"Clinicoecon Outcomes Res"},{"key":"key2024090911500500_ref92-bib92","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1056\/NEJMoa1611310","article-title":"Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer","volume":"375","author":"Mirza","year":"2016","journal-title":"N Engl J Med"},{"key":"key2024090911500500_ref93-bib93","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1200\/JCO.19.03107","article-title":"Patient-centered outcomes in ARIEL3, a Phase III, randomized, placebo-controlled trial of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma","volume":"38","author":"Oza","year":"2020","journal-title":"J Clin Oncol"},{"key":"key2024090911500500_ref94-bib94","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S1470-2045(18)30333-4","article-title":"Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16\/NOVA): results from a double-blind, phase 3, randomised controlled trial","volume":"19","author":"Oza","year":"2018","journal-title":"Lancet Oncol"},{"key":"key2024090911500500_ref95-bib95","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/intqhc\/mzy162","article-title":"Obesity in total laparoscopic hysterectomy for early stage endometrial cancer: health gain and inpatient resource use","volume":"31","author":"Armfield","year":"2019","journal-title":"Int J Qual Health Care"},{"key":"key2024090911500500_ref96-bib96","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2010.11.043","article-title":"Cost effectiveness of laparoscopy versus laparotomy in early stage endometrial cancer: a randomised trial","volume":"121","author":"Bijen","year":"2011","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref97-bib97","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.AOG.0000133481.74113.f3","article-title":"Tamoxifen for breast cancer prevention: a framework for clinical decisions","volume":"104","author":"Cykert","year":"2004","journal-title":"Obstet Gynecol"},{"key":"key2024090911500500_ref98-bib98","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2018.04.558","article-title":"Prospective cohort study comparing quality of life and sexual health outcomes between women undergoing robotic, laparoscopic and open surgery for endometrial cancer","volume":"149","author":"Ferguson","year":"2018","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref99-bib99","first-page":"829","article-title":"Health utilities in gynecological oncology and mastology in Germany","volume":"34","author":"Hildebrandt","year":"2014","journal-title":"Anticancer Res"},{"key":"key2024090911500500_ref100-bib100","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/cncr.29119","article-title":"Health-related quality of life in older adult survivors of selected cancers: data from the SEER-MHOS linkage","volume":"121","author":"Kent","year":"2015","journal-title":"Cancer"},{"key":"key2024090911500500_ref101-bib101","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11136-014-0828-z","article-title":"The relationship between economic characteristics and health-related quality of life in newly diagnosed cancer patients in Southeast Asia: results from an observational study","volume":"24","author":"Kimman","year":"2015","journal-title":"Qual Life Res"},{"key":"key2024090911500500_ref102-bib102","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1136\/ijgc-2020-001611","article-title":"Cost-effectiveness of robotic hysterectomy versus abdominal hysterectomy in early endometrial cancer","volume":"30","author":"Lundin","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"key2024090911500500_ref103-bib103","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/ijgc-2019-000285","article-title":"A prospective randomized assessment of quality of life between open and robotic hysterectomy in early endometrial cancer","volume":"29","author":"Lundin","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"key2024090911500500_ref104-bib104","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/sj.bjc.6603804","article-title":"Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC (\u2018Arimidex\u2019, Tamoxifen alone or in combination) trial","volume":"97","author":"Mansel","year":"2007","journal-title":"Br J Cancer"},{"key":"key2024090911500500_ref105-bib105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40271-016-0190-z","article-title":"EQ-5D health utility scores: data from a comprehensive Canadian cancer centre","volume":"10","author":"Naik","year":"2017","journal-title":"Patient"},{"key":"key2024090911500500_ref106-bib106","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.vhri.2017.07.010","article-title":"Health-related quality of life of patients with HPV-related cancers in Indonesia","volume":"15","author":"Setiawan","year":"2018","journal-title":"Value Health Reg Issues"},{"key":"key2024090911500500_ref107-bib107","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/0167482X.2019.1708321","article-title":"Patient-reported outcomes after surgery among patients with gynecological diseases in Japan","volume":"42","author":"Ueno","year":"2021","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"key2024090911500500_ref108-bib108","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2014.10.020","article-title":"A cost-utility analysis of NRG Oncology\/Gynecologic Oncology Group Protocol 218: incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancer","volume":"136","author":"Cohn","year":"2015","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref109-bib109","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/IGC.0000000000001271","article-title":"Economic analysis of neoadjuvant chemotherapy versus primary debulking surgery for advanced epithelial ovarian cancer using an aggressive surgical paradigm","volume":"28","author":"Cole","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"key2024090911500500_ref110-bib110","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.3747\/co.23.3139","article-title":"The cost-effectiveness of bevacizumab for the treatment of advanced ovarian cancer in Canada","volume":"23","author":"Duong","year":"2016","journal-title":"Curr Oncol"},{"key":"key2024090911500500_ref111-bib111","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/annonc\/mdx796","article-title":"Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy","volume":"29","author":"Friedlander","year":"2018","journal-title":"Ann Oncol"},{"key":"key2024090911500500_ref112-bib112","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/annonc\/mdw147","article-title":"Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1)","volume":"27","author":"Fujiwara","year":"2016","journal-title":"Ann Oncol"},{"key":"key2024090911500500_ref113-bib113","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/IGC.0b013e3181dbd13f","article-title":"Medical costs and outcomes for Australian women with ovarian cancer: a patient-level analysis over 2.5 years","volume":"20","author":"Gordon","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"key2024090911500500_ref114-bib114","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10549-009-0373-6","article-title":"Breast cancer-related preferences among women with and without BRCA mutations","volume":"119","author":"Grann","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"key2024090911500500_ref115-bib115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ygyno.2008.12.026","article-title":"Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment","volume":"113","author":"Havrilesky","year":"2009","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref116-bib116","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/cncr.26199","article-title":"Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer","volume":"118","author":"Havrilesky","year":"2012","journal-title":"Cancer"},{"key":"key2024090911500500_ref117-bib117","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1002\/cncr.32447","article-title":"Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer","volume":"125","author":"Havrilesky","year":"2019","journal-title":"Cancer"},{"key":"key2024090911500500_ref118-bib118","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ygyno.2012.10.024","article-title":"Comparison of methods to estimate health state utilities for ovarian cancer using quality of life data: a Gynecologic Oncology Group study","volume":"128","author":"Hess","year":"2013","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref119-bib119","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ehrm.2010.02.001","article-title":"Preferences of patients and oncologists for advanced ovarian cancer treatment-related health states","volume":"1","author":"Hess","year":"2010","journal-title":"Health Outcomes Res mEd"},{"key":"key2024090911500500_ref120-bib120","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jval.2016.01.013","article-title":"The cost-effectiveness of bevacizumab in advanced ovarian cancer using evidence from the ICON7 trial","volume":"19","author":"Hinde","year":"2016","journal-title":"Value Health"},{"key":"key2024090911500500_ref121-bib121","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ygyno.2012.06.034","article-title":"Patient-reported outcomes in relapsed ovarian cancer: results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD alone","volume":"127","author":"Krasner","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref122-bib122","doi-asserted-by":"crossref","first-page":"799","DOI":"10.7314\/APJCP.2016.17.2.799","article-title":"Cost effectiveness analysis of different management strategies between best supportive care and second-line chemotherapy for platinum-resistant or refractory ovarian cancer","volume":"17","author":"Luealon","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"key2024090911500500_ref124-bib124","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1006\/gyno.1997.4786","article-title":"Cost-utility analysis of paclitaxel in combination with cisplatin for patients with advanced ovarian cancer","volume":"66","author":"Ortega","year":"1997","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref125-bib125","doi-asserted-by":"crossref","first-page":"763.e1","DOI":"10.1016\/j.ajog.2015.01.053","article-title":"Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced-stage ovarian cancer in patients 65 years old or older","volume":"212","author":"Rowland","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"key2024090911500500_ref126-bib126","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejca.2006.09.007","article-title":"Putting the \u2018Q\u2019 in quality adjusted life years (QALYs) for advanced ovarian cancer: an approach using data clustering methods and the internet","volume":"43","author":"Stein","year":"2007","journal-title":"Eur J Cancer"},{"key":"key2024090911500500_ref127-bib127","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ygyno.2017.06.019","article-title":"Cost-effectiveness of laparoscopy as diagnostic tool before primary cytoreductive surgery in ovarian cancer","volume":"146","author":"van de Vrie","year":"2017","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref128-bib128","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1200\/jco.2002.08.035","article-title":"Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy","volume":"20","author":"van Roosmalen","year":"2002","journal-title":"J Clin Oncol"},{"key":"key2024090911500500_ref129-bib129","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1600-0412.2010.01058.x","article-title":"Health-related quality of life and postoperative recovery in fast-track hysterectomy","volume":"90","author":"Borendal Wodlin","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key2024090911500500_ref130-bib130","doi-asserted-by":"crossref","first-page":"e017782","DOI":"10.1136\/bmjopen-2017-017782","article-title":"Cost-effectiveness of an internet-based perioperative care programme to enhance postoperative recovery in gynaecological patients: economic evaluation alongside a stepped-wedge cluster-randomised trial","volume":"8","author":"Bouwsma","year":"2018","journal-title":"BMJ Open"},{"key":"key2024090911500500_ref131-bib131","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/aogs.13670","article-title":"Outpatient vs inpatient total laparoscopic hysterectomy: a randomized controlled trial","volume":"98","author":"Christiansen","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key2024090911500500_ref132-bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23530","article-title":"Laparoscopic supracervical hysterectomy compared with second-generation endometrial ablation for heavy menstrual bleeding: the HEALTH RCT","volume":"23","author":"Cooper","year":"2019","journal-title":"Health Technol Assess"},{"key":"key2024090911500500_ref133-bib133","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/0144361021000003681","article-title":"Quality of life studies in unselected gynaecological outpatients and inpatients before and after hysterectomy","volume":"22","author":"Davies","year":"2002","journal-title":"J Obstet Gynaecol"},{"key":"key2024090911500500_ref134-bib134","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.AOG.0000292083.97478.38","article-title":"Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: a randomized controlled trial","volume":"110","author":"Dickersin","year":"2007","journal-title":"Obstet Gynecol"},{"key":"key2024090911500500_ref135-bib135","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1148\/radiol.11100704","article-title":"Quality-of-life assessment of fibroid treatment options and outcomes","volume":"259","author":"Fennessy","year":"2011","journal-title":"Radiology"},{"key":"key2024090911500500_ref136-bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta8260","article-title":"EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy","volume":"8","author":"Garry","year":"2004","journal-title":"Health Technol Assess"},{"key":"key2024090911500500_ref137-bib137","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00404-008-0615-6","article-title":"Hysterectomy and women satisfaction: total versus subtotal technique","volume":"278","author":"Gorlero","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"key2024090911500500_ref138-bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta24130","article-title":"Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs","volume":"24","author":"Hemming","year":"2020","journal-title":"Health Technol Assess"},{"key":"key2024090911500500_ref139-bib139","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/AOG.0b013e318292aea4","article-title":"Contributions of hysterectomy and uterus-preserving surgery to health-related quality of life","volume":"122","author":"Kuppermann","year":"2013","journal-title":"Obstet Gynecol"},{"key":"key2024090911500500_ref140-bib140","first-page":"1217","article-title":"Bowel dysfunction after total abdominal hysterectomy for benign conditions: a prospective longitudinal study","volume":"25","author":"Lashen","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key2024090911500500_ref141-bib141","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/jsm.12623","article-title":"Influences of different hysterectomy techniques on patients\u2019 postoperative sexual function and quality of life","volume":"11","author":"Radosa","year":"2014","journal-title":"J Sex Med"},{"key":"key2024090911500500_ref142-bib142","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1017\/S0266462300012277","article-title":"A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia","volume":"14","author":"Sculpher","year":"1998","journal-title":"Int J Technol Assess Health Care"},{"key":"key2024090911500500_ref143-bib143","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3109\/00016340903317990","article-title":"Costs and health-related quality of life effects of hysterectomy in patients with benign uterine disorders","volume":"88","author":"Taipale","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key2024090911500500_ref144-bib144","volume-title":"Fast Track Abdominal Hysterectomy: On the Mode of Anesthesia, Postoperative Recovery and Health Economics","author":"Borendal Wodlin","year":"2011"},{"key":"key2024090911500500_ref145-bib145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/bmj.37942.601331.EE","article-title":"Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: results from a randomised trial","volume":"328","author":"Sculpher","year":"2004","journal-title":"BMJ"},{"key":"key2024090911500500_ref146-bib146","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40273-016-0479-8","article-title":"Benefits, challenges and potential strategies of open source health economic models","volume":"35","author":"Dunlop","year":"2017","journal-title":"PharmacoEcon"},{"key":"key2024090911500500_ref147-bib147","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jval.2012.07.008","article-title":"Whole disease modeling to inform resource allocation decisions in cancer: a methodological framework","volume":"15","author":"Tappenden","year":"2012","journal-title":"Value Health"},{"key":"key2024090911500500_ref148-bib148","volume-title":"SimPy","author":"Team SimPy","year":"2022"},{"key":"key2024090911500500_ref149-bib149","volume-title":"Welcome to Injector\u2019s Documentation!","author":"Thomas","year":"2022"},{"key":"key2024090911500500_ref150-bib150","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array programming with NumPy","volume":"585","author":"Harris","year":"2020","journal-title":"Nature"},{"key":"key2024090911500500_ref151-bib151","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat Methods"},{"key":"key2024090911500500_ref152-bib152","volume-title":"pytest 7.1","author":"Krekel","year":"2004"},{"key":"key2024090911500500_ref155-bib155","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ijc.31300","article-title":"Three molecular pathways model colorectal carcinogenesis in Lynch syndrome","volume":"143","author":"Ahadova","year":"2018","journal-title":"Int J Cancer"},{"key":"key2024090911500500_ref156-bib156","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ijc.33224","article-title":"The \u2018unnatural\u2019 history of colorectal cancer in Lynch syndrome: lessons from colonoscopy surveillance","volume":"148","author":"Ahadova","year":"2021","journal-title":"Int J Cancer"},{"key":"key2024090911500500_ref157-bib157","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13053-019-0106-8","article-title":"Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report","volume":"17","author":"Sepp\u00e4l\u00e4","year":"2019","journal-title":"Hered Cancer Clin Pract"},{"key":"key2024090911500500_ref158-bib158","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1053\/j.gastro.2018.07.030","article-title":"No difference in colorectal cancer incidence or stage at detection by colonoscopy among 3 countries with different Lynch syndrome surveillance policies","volume":"155","author":"Engel","year":"2018","journal-title":"Gastroenterology"},{"key":"key2024090911500500_ref159-bib159","doi-asserted-by":"crossref","first-page":"e1008970","DOI":"10.1371\/journal.pcbi.1008970","article-title":"Mathematical modeling of multiple pathways in colorectal carcinogenesis using dynamical systems with Kronecker structure","volume":"17","author":"Haupt","year":"2021","journal-title":"PLOS Comput Biol"},{"key":"key2024090911500500_ref160-bib160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/1940-6207.CAPR-10-0262","article-title":"Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population","volume":"4","author":"Dinh","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"key2024090911500500_ref161-bib161","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1158\/1940-6207.CAPR-20-0620","article-title":"The costs and benefits of risk stratification for colorectal cancer screening based on phenotypic and genetic risk: a health economic analysis","volume":"14","author":"Thomas","year":"2021","journal-title":"Cancer Prev Res (Phila)"},{"key":"key2024090911500500_ref162-bib162","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12885-020-07771-8","article-title":"Comparison of long-term outcomes between Lynch sydrome and sporadic colorectal cancer: a propensity score matching analysis","volume":"21","author":"Xu","year":"2021","journal-title":"BMC Cancer"},{"key":"key2024090911500500_ref163-bib163","volume-title":"Cancer Survival in England: Adults Diagnosed Between 2013 and 2017 and Followed up to 2018","author":"Office for National Statistics","year":"2019"},{"key":"key2024090911500500_ref164-bib164","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41416-018-0029-6","article-title":"The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015","volume":"118","author":"Brown","year":"2018","journal-title":"Br J Cancer"},{"key":"key2024090911500500_ref165-bib165","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1200\/JCO.2018.78.4777","article-title":"Cancer risks for PMS2-associated Lynch syndrome","volume":"36","author":"ten Broeke","year":"2018","journal-title":"J Clin Oncol"},{"key":"key2024090911500500_ref166-bib166","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.maturitas.2009.02.005","article-title":"Endometrial hyperplasia and the risk of progression to carcinoma","volume":"63","author":"Lacey","year":"2009","journal-title":"Maturitas"},{"key":"key2024090911500500_ref167-bib167","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.bjc.6604102","article-title":"Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan","volume":"98","author":"Lacey","year":"2007","journal-title":"Br J Cancer"},{"key":"key2024090911500500_ref168-bib168","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.3390\/ijms23052531","article-title":"Fertility-sparing approaches in atypical endometrial hyperplasia and endometrial cancer patients: current evidence and future directions","volume":"23","author":"Contreras","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key2024090911500500_ref169-bib169","doi-asserted-by":"crossref","first-page":"191.e1","DOI":"10.1016\/j.ajog.2020.08.032","article-title":"Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer","volume":"224","author":"Westin","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"key2024090911500500_ref170-bib170","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1158\/1940-6207.CAPR-21-0229","article-title":"Weight loss during intrauterine progestin treatment for obesity-associated atypical hyperplasia and early-stage cancer of the endometrium","volume":"14","author":"Barr","year":"2021","journal-title":"Cancer Prev Res"},{"key":"key2024090911500500_ref171-bib171","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet Gynecol"},{"key":"key2024090911500500_ref172-bib172","doi-asserted-by":"crossref","first-page":"e0221419","DOI":"10.1371\/journal.pone.0221419","article-title":"Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting","volume":"14","author":"Snowsill","year":"2019","journal-title":"PLOS ONE"},{"key":"key2024090911500500_ref173-bib173","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ygyno.2020.09.039","article-title":"Clinicopathologic characteristics and outcomes of endometrial cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening","volume":"159","author":"Carr","year":"2020","journal-title":"Gynecol Oncol"},{"key":"key2024090911500500_ref174-bib174","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/jnci\/djab029","article-title":"Prevalence and prognosis of Lynch syndrome and sporadic mismatch repair deficiency in endometrial cancer","volume":"113","author":"Post","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"key2024090911500500_ref175-bib175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2009.068130","article-title":"Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds","volume":"47","author":"Grindedal","year":"2010","journal-title":"J Med Genet"},{"key":"key2024090911500500_ref176-bib176","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1097-0142(20001015)89:8<1765::AID-CNCR17>3.0.CO;2-F","article-title":"The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis","volume":"89","author":"Dijkhuizen","year":"2000","journal-title":"Cancer"},{"key":"key2024090911500500_ref177-bib177","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejca.2021.02.022","article-title":"Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a prospective Lynch syndrome database report","volume":"148","author":"Sepp\u00e4l\u00e4","year":"2021","journal-title":"Eur J Cancer"},{"key":"key2024090911500500_ref178-bib178","author":"Office for National Statistics","year":"2021","journal-title":"Past and Projected Period and Cohort Life Tables: 2020-Based, UK, 1981 to 2070"},{"key":"key2024090911500500_ref179-bib179","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3390\/jcm9061664","article-title":"Cost-effectiveness of the Manchester approach to identifying Lynch syndrome in women with endometrial cancer","volume":"9","author":"Snowsill","year":"2020","journal-title":"J Clin Med"},{"key":"key2024090911500500_ref180-bib180","volume-title":"CancerData: Staging Data in England","author":"National Disease Registration Service (NDRS)","year":"2021"},{"key":"key2024090911500500_ref181-bib181","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1200\/JCO.2009.24.1315","article-title":"Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia","volume":"28","author":"Lacey","year":"2010","journal-title":"J Clin Oncol"},{"key":"key2024090911500500_ref182-bib182","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41431-019-0538-7","article-title":"Microsatellite instability screening in colorectal adenomas to detect Lynch syndrome patients? A systematic review and meta-analysis","volume":"28","author":"Dabir","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"key2024090911500500_ref183-bib183","volume-title":"National Cost Collection for the NHS","author":"National Health Service England","year":"2022"},{"key":"key2024090911500500_ref184-bib184","volume-title":"Unit Costs of Health and Social Care 2021","author":"Jones","year":"2021"},{"key":"key2024090911500500_ref185-bib185","volume-title":"Interactive Costing Tool (iCT): Getting Started","author":"National Institute for Health and Care Research (NIHR)","year":"2019"},{"key":"key2024090911500500_ref186-bib186","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/bjc.2017.222","article-title":"The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"117","author":"Menon","year":"2017","journal-title":"Br J Cancer"},{"key":"key2024090911500500_ref187-bib187","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jamaoncol.2016.1842","article-title":"Use of CA-125 tests and computed tomographic scans for surveillance in ovarian cancer","volume":"2","author":"Esselen","year":"2016","journal-title":"JAMA Oncol"},{"key":"key2024090911500500_ref188-bib188","volume-title":"Prescription Cost Analysis (PCA) \u2013 Financial Year 2021\/22","author":"National Health Service Business Services Authority","year":"2022"},{"key":"key2024090911500500_ref189-bib189","volume-title":"NHS Electronic Drug Tariff (July 2022)","author":"National Health Service Business Services Authority, NHS Prescription Services","year":"2022"},{"key":"key2024090911500500_ref191-bib191","doi-asserted-by":"crossref","first-page":"e0165539","DOI":"10.1371\/journal.pone.0165539","article-title":"Long-term secondary care costs of endometrial cancer: a prospective cohort study nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"11","author":"Pennington","year":"2016","journal-title":"PLOS ONE"},{"key":"key2024090911500500_ref192-bib192","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22440","article-title":"Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis","volume":"22","author":"Westwood","year":"2018","journal-title":"Health Technol Assess"},{"key":"key2024090911500500_ref193-bib193","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/bjc.2016.77","article-title":"Cost of care for cancer patients in England: evidence from population-based patient-level data","volume":"114","author":"Laudicella","year":"2016","journal-title":"Br J Cancer"},{"key":"key2024090911500500_ref194-bib194","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta25420","article-title":"Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation","volume":"25","author":"Stinton","year":"2021","journal-title":"Health Technol Assess"},{"key":"key2024090911500500_ref196-bib196","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1524-4733.2010.00700.x","article-title":"Populating an economic model with health state utility values: moving toward better practice","volume":"13","author":"Ara","year":"2010","journal-title":"Value Health"},{"key":"key2024090911500500_ref197-bib197","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/hec.1373","article-title":"A linear index for predicting joint health-states utilities from single health-states utilities","volume":"18","author":"Basu","year":"2009","journal-title":"Health Econ"},{"key":"key2024090911500500_ref198-bib198","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s10198-004-0264-z","article-title":"Validating the EQ-5D with time trade off for the German population","volume":"6","author":"Greiner","year":"2005","journal-title":"Eur J Health Econ"},{"key":"key2024090911500500_ref199-bib199","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/0272989X14536779","article-title":"A review and meta-analysis of colorectal cancer utilities","volume":"34","author":"Djalalov","year":"2014","journal-title":"Med Decis Making"},{"key":"key2024090911500500_ref200-bib200","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1177\/0272989X98018002S09","article-title":"Net health benefits","volume":"18","author":"Stinnett","year":"2016","journal-title":"Med Decis Making"},{"key":"key2024090911500500_ref201-bib201","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0272989X13505910","article-title":"Estimating multiparameter partial expected value of perfect information from a probabilistic sensitivity analysis sample","volume":"34","author":"Strong","year":"2013","journal-title":"Med Decis Making"},{"key":"key2024090911500500_ref202-bib202","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jval.2017.03.009","article-title":"A systematic review of the techniques used to value temporary health states","volume":"20","author":"Ogwulu","year":"2017","journal-title":"Value Health"},{"key":"key2024090911500500_ref203-bib203","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/11317060-000000000-00000","article-title":"Methods for measuring temporary health states for cost-utility analyses","volume":"27","author":"Wright","year":"2009","journal-title":"PharmacoEcon"},{"key":"key2024090911500500_ref204-bib204","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jclinepi.2004.10.005","article-title":"Quality-adjusted life years was a poor predictor of women\u2019s willingness to pay in acute and chronic conditions: results of a survey","volume":"58","author":"Franic","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"key2024090911500500_ref205-bib205","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jval.2018.02.004","article-title":"Quality-adjusted life-years without constant proportionality","volume":"21","author":"Craig","year":"2018","journal-title":"Value Health"},{"key":"key2024090911500500_ref206-bib206","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.acra.2017.10.011","article-title":"Understanding patient preference in female pelvic imaging","volume":"25","author":"Sakala","year":"2018","journal-title":"Acad Radiol"},{"key":"key2024090911500500_ref207-bib207","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1600-0412.2011.01091.x","article-title":"A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families","volume":"90","author":"Auranen","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key2024090911500500_ref208-bib208","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2015.12.005","article-title":"Ovarian cancer in Lynch syndrome; a systematic review","volume":"55","author":"Helder-Woolderink","year":"2016","journal-title":"Eur J Cancer"},{"key":"key2024090911500500_ref209-bib209","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/ijgc-2021-003132","article-title":"Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review","volume":"32","author":"Lim","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"key2024090911500500_ref210-bib210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7326\/0003-4819-155-2-201107190-00002","article-title":"Strategies to identify the Lynch syndrome among patients with colorectal cancer","volume":"155","author":"Ladabaum","year":"2011","journal-title":"Ann Intern Med"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2045884","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/VBXX6307\/VBXX6307.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2045884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T06:34:23Z","timestamp":1725863663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/VBXX6307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":201,"alternative-id":["10.3310\/VBXX6307"],"URL":"https:\/\/doi.org\/10.3310\/vbxx6307","relation":{},"ISSN":["2046-4924"],"issn-type":[{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"09-2020","name":"contractual_start_date","label":"contractual_start_date","group":{"name":"article_history","label":"Article History"}},{"value":"08-2022","name":"editorial_review_begun","label":"editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"03-2023","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}